Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearches for rohm semaglutide are increasing in the UK, and the core question behind most of them is straightforward: is this a legitimate way to access semaglutide for weight loss? The short answer is no. Rohm Labs is not a licensed medicines manufacturer in the UK, and semaglutide sold under that name has no MHRA marketing authorisation. Semaglutide for weight management in the UK is available only as Wegovy, a Prescription-Only Medicine made by Novo Nordisk, requiring a clinical assessment before a prescriber can issue a prescription. If you have landed here because you are trying to work out whether rohm semaglutide is a safe or legal option, this page explains the picture clearly so you can make an informed choice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Rohm Labs is a brand associated with unlicensed pharmaceutical compounds, often sold through bodybuilding or grey-market supplement channels. If you want to understand exactly what rohm labs semaglutide is and how it differs from licensed alternatives, the details matter before making any decision. That matters for one concrete reason: the Human Medicines Regulations 2012 require that any medicine sold in the UK holds a valid marketing authorisation. Rohm semaglutide does not.
This is not a technicality. Medicines that carry an MHRA authorisation have been through documented manufacturing standards, stability testing and clinical trial review. Products sold without that process could contain the wrong concentration, inactive filler instead of the active ingredient, or something else entirely. The MHRA has publicly confirmed that inspections of unlicensed weight-loss injectables have found pens containing insulin, a substance that, injected at the wrong dose, can cause a life-threatening drop in blood sugar. You can report suspect products directly through the MHRA's Yellow Card scheme.
The decision in front of anyone searching for rohm semaglutide is really a question about risk tolerance: save money now using a product with no verified content, or access a licensed medicine through a route where a real clinician is accountable for your care. Those are not equivalent options.
Licensed semaglutide for weight management comes in two forms, both called Wegovy and both made by Novo Nordisk. The weekly injection has been available in the UK since 2023 and has a well-documented trial record, the STEP 1 clinical trial, published in the New England Journal of Medicine, found an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose in adults with obesity. In June 2026, the MHRA also approved an oral version: a once-daily tablet taken before breakfast, with a maintenance dose of 25mg, making the UK the first country in Europe to license an oral GLP-1 for weight loss.
Both forms require a prescription, which means a qualified prescriber must review your health history before treatment can start. That review is the mechanism that keeps you safe: it checks for contraindications, considers other medicines you take, and sets the right starting point. If you are exploring what semaglutide treatment actually involves, our Wegovy overview covers how it works, what to expect and who it is licensed for.
Cost is often what drives people toward unlicensed sources. If that is the factor for you, our page on where to buy Wegovy in the UK sets out the legitimate private routes honestly, including what a transparent price should include. Worth reading before drawing conclusions.
The MHRA has issued clear public guidance on how to spot unlicensed weight-loss medicines online. Red flags include: sellers who do not ask for a prescription or medical history; prices significantly below the known private market range; social media sellers; and products described as rohm, research-grade, peptide or generic semaglutide. These descriptions signal that the product is outside the licensed supply chain.
A GPhC-registered pharmacy is the standard to check against. The General Pharmaceutical Council maintains a public register at pharmacyregulation.org/registers where you can verify any online pharmacy in seconds. If a seller is not listed there, they are not legally permitted to dispense prescription medicines in the UK.
At nume, our pharmacy is GPhC-registered (premises number 9012878) and every consultation is read by a GPhC-registered Independent Prescriber. If you want to understand the full picture of how our clinical process works, the about us page sets it out plainly. Our medicines come through the licensed UK supply chain (meaning the Novo Nordisk authorised distribution network) so what arrives is what it says it is. When an order goes out, you get DPD tracking on your phone and a plain, unbranded box; there is nothing to identify the contents to anyone but you.
If you have been using an unlicensed semaglutide product, tell a healthcare professional. This is not about getting into trouble, it is about making sure your care is joined up. A GP or prescriber needs to know what you have been taking to assess your current health status accurately, to check for interactions with anything else you use, and to decide whether transitioning to a licensed product makes sense for you.
People who switch to licensed Wegovy from an unlicensed source are treated as new patients at nume: a full clinical review happens before any prescription is issued, regardless of what was taken before. That includes identity verification, a weight check and a review of your medical history, and our page on semaglutide treatment covers what that process involves in full. The semaglutide monitoring panel we offer can also give a baseline picture of relevant health markers before or during treatment. If you have questions before starting, our team is reachable through the contact page and our prescribers are available for aftercare seven days a week.
The right next step, if you are ready to explore licensed weight-loss treatment, is a free consultation. A prescriber reads your answers the same day and there is no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.